Ophthalmic Drug Delivery Systems Market Size, Share & Trends Analysis Report By Technology (Eye Drops, Contact Lenses), By Delivery Route, By Production Technology, By Material, By Region, And Segment Forecasts, 2025 - 2030

PUBLISHED: November 25, 2024

PAGES: 190 Pages

DELIVERY TIME: 2-10 business days

ADD TO COMPARE

SELECT AN OPTION

The global ophthalmic drug delivery systems market size is projected to reach USD 23.36 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.6% from 2025 to 2030. Factors such as growing prevalence of ophthalmic diseases, rise in number of ophthalmic procedures that require attentive post procedural care and increase in need to deliver controlled dosage forms for pediatric and geriatric population are anticipated to propel the growth of the market. In addition, immense focus on technological advancements is further helping the market to grow at a significant rate. For instance, manufacturers' instant focus on nanotechnology has helped to deliver error-free drug delivery and increase the penetration level of the drug at the target site.

The market observed a sudden fall in sales of ophthalmic drug delivery systems during the first half of the COVID-19 pandemic. The lockdowns across different countries and various restrictions led down by the government led to fall in number of patient's visits to the hospitals and clinics. Moreover, the disruption in supply chains also led to a shortage of these products which indicates an overall negative impact on the market. However, with the government's initiatives to curb the spread of the virus and limit the negative consequences it possesses via mass vaccination programs and heavy investment in R&D activities, the market is expected to recover over the forecast period.

Ophthalmic Drug Delivery Systems Market Report Highlights:

The eye drops segment dominated the market with highest revenue share in 2024 as eye drops are often recommended as the first line of treatment in most of the ophthalmic procedures to control the effect of the disease as it is the most convenient and patient compliant technology.
The intraocular segment held the highest revenue share in 2024 owing to the advantages it offers such as sterilization, less irritation, ease of eye drops formulation and enhancement in ocular bioavailability of drugs that are insoluble in tear fluid.
On the basis of production technology, the formulation segment accounted for highest market share in 2024 owing to increase in adoption of topical eye drops which is produced through the formulation technology.
Based on material, the hydrogels segment held the highest market share in 2024 owing to the advantages it offers over other materials.
North America accounted for highest market share in 2024 due to increasing incidence of ophthalmic disorders, presence of skilled professionals and various initiatives undertaken by the government agencies to prevent blindness in the region.
The COVID-19 pandemic has a negative impact on the market. Due to change in healthcare priorities, social distancing, worldwide lockdowns led to reduced patient visits to the hospitals and clinics.

Product Code: GVR-4-68039-917-7

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.2. Market Definitions
- 1.2.1. Technology Segment
- 1.2.2. Delivery Route Segment
- 1.2.3. Production Technology Segment
- 1.2.4. Material Segment
1.3. Information analysis
- 1.3.1. Market formulation & data visualization
1.4. Data validation & publishing
1.5. Information Procurement
- 1.5.1. Primary Research
1.6. Information or Data Analysis
1.7. Market Formulation & Validation
1.8. Market Model
1.9. Total Market: CAGR Calculation
1.10. Objectives
- 1.10.1. Objective 1
- 1.10.2. Objective 2

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Snapshot
2.3. Segment Snapshot
2.4. Competitive Insights Landscape

Chapter 3. Ophthalmic Drug Delivery Systems Market Variables, Trends & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.2. Market restraint analysis
3.3. Ophthalmic Drug Delivery Systems Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.2. PESTEL Analysis
- 3.3.3. COVID-19 Impact Analysis

Chapter 4. Ophthalmic Drug Delivery Systems Market: Technology Estimates & Trend Analysis

4.1. Segment Dashboard
4.2. Global Ophthalmic Drug Delivery Systems Market Technology Movement Analysis
4.3. Global Ophthalmic Drug Delivery Systems Market Size & Trend Analysis, by Technology, 2018 - 2030 (USD Billion)
4.4. Eye Drops
- 4.4.1. Market estimates and forecast 2018 - 2030 (USD Million)
4.5. Contact Lenses
- 4.5.1. Market estimates and forecast 2018 - 2030 (USD Million)
4.6. Punctal Plugs
- 4.6.1. Market estimates and forecast 2018 - 2030 (USD Million)
4.7. Episcleral Implants
4.8. Intraviteal Implants
- 4.8.1. Market estimates and forecast 2018 - 2030 (USD Million)
4.9. Injectable Particulate Systems
- 4.9.1. Market estimates and forecast 2018 - 2030 (USD Million)
4.10. Iontophoresis
- 4.10.1. Market estimates and forecast 2018 - 2030 (USD Million)
4.11. Micro-Electromechanical
- 4.11.1. Market estimates and forecast 2018 - 2030 (USD Million)
4.12. Nano careers
- 4.12.1. Market estimates and forecast 2018 - 2030 (USD Million)
4.13. Nano microparticles
- 4.13.1. Market estimates and forecast 2018 - 2030 (USD Million)
4.14. Microneedles
- 4.14.1. Market estimates and forecast 2018 - 2030 (USD Million)
4.15. Hydrogels
- 4.15.1. Market estimates and forecast 2018 - 2030 (USD Million)
4.16. Others
- 4.16.1. Market estimates and forecast 2018 - 2030 (USD Million)

Chapter 5. Ophthalmic Drug Delivery Systems Market: Delivery Route Estimates & Trend Analysis

5.1. Segment Dashboard
5.2. Global Ophthalmic Drug Delivery Systems Market Delivery Route Movement Analysis
5.3. Global Ophthalmic Drug Delivery Systems Market Size & Trend Analysis, by Delivery Route, 2018 - 2030 (USD Billion)
5.4. Electrospinning
- 5.4.1. Market estimates and forecast 2018 - 2030 (USD Million)
5.5. 3D Printing
- 5.5.1. Market estimates and forecast 2018 - 2030 (USD Million)
5.6. Extrusion
- 5.6.1. Market estimates and forecast 2018 - 2030 (USD Million)
5.7. Formulation
- 5.7.1. Market estimates and forecast 2018 - 2030 (USD Million)
5.8. Micropatterning
- 5.8.1. Market estimates and forecast 2018 - 2030 (USD Million)
5.9. Compression molding
- 5.9.1. Market estimates and forecast 2018 - 2030 (USD Million)
5.10. Others
- 5.10.1. Market estimates and forecast 2018 - 2030 (USD Million)

Chapter 6. Ophthalmic Drug Delivery Systems Market: Production Technology Estimates & Trend Analysis

6.1. Segment Dashboard
6.2. Global Ophthalmic Drug Delivery Systems Market Production Technology Movement Analysis
6.3. Global Ophthalmic Drug Delivery Systems Market Size & Trend Analysis, by Production Technology, 2018 - 2030 (USD Billion)
6.4. Liposomes
- 6.4.1. Market estimates and forecast 2018 - 2030 (USD Million)
6.5. Collagen
- 6.5.1. Market estimates and forecast 2018 - 2030 (USD Million)
6.6. PLA-PEG
- 6.6.1. Market estimates and forecast 2018 - 2030 (USD Million)
6.7. PDO/PVA
- 6.7.1. Market estimates and forecast 2018 - 2030 (USD Million)
6.8. Hydrogels
- 6.8.1. Market estimates and forecast 2018 - 2030 (USD Million)
6.9. TMC
- 6.9.1. Market estimates and forecast 2018 - 2030 (USD Million)
6.10. Polyorthoesters
- 6.10.1. Market estimates and forecast 2018 - 2030 (USD Million)
6.11. PLGA
- 6.11.1. Market estimates and forecast 2018 - 2030 (USD Million)
6.12. Fatty acids
- 6.12.1. Market estimates and forecast 2018 - 2030 (USD Million)
6.13. Others
- 6.13.1. Market estimates and forecast 2018 - 2030 (USD Million)

Chapter 7. Ophthalmic Drug Delivery Systems Market: Material Estimates & Trend Analysis

7.1. Segment Dashboard
7.2. Global Ophthalmic Drug Delivery Systems Market Material Movement Analysis
7.3. Global Ophthalmic Drug Delivery Systems Market Size & Trend Analysis, by Material, 2018 - 2030 (USD Billion)
7.4. Liposomes
- 7.4.1. Market estimates and forecast 2018 - 2030 (USD Million)
7.5. Collagen
- 7.5.1. Market estimates and forecast 2018 - 2030 (USD Million)
7.6. PLA-PEG
- 7.6.1. Market estimates and forecast 2018 - 2030 (USD Million)
7.7. PDO/PVA
- 7.7.1. Market estimates and forecast 2018 - 2030 (USD Million)
7.8. Hydrogels
- 7.8.1. Market estimates and forecast 2018 - 2030 (USD Million)
7.9. TMC
- 7.9.1. Market estimates and forecast 2018 - 2030 (USD Million)
7.10. Polyorthoesters
- 7.10.1. Market estimates and forecast 2018 - 2030 (USD Million)
7.11. PLGA
- 7.11.1. Market estimates and forecast 2018 - 2030 (USD Million)
7.12. Fatty acids
- 7.12.1. Market estimates and forecast 2018 - 2030 (USD Million)
7.13. Others
- 7.13.1. Market estimates and forecast 2018 - 2030 (USD Million)

Chapter 8. Ophthalmic Drug Delivery Systems Market: Regional Estimates & Trend Analysis

8.1. Regional Market Share Analysis, 2023 & 2030
8.2. Regional Market Dashboard
8.3. Market Size, & Forecasts Trend Analysis, 2018 - 2030:
8.4. North America
- 8.4.1. U.S.
  - 8.4.1.1. Key country dynamics
  - 8.4.1.2. Competitive scenario
  - 8.4.1.3. Regulatory framework
  - 8.4.1.4. U.S. market estimates and forecasts 2018 - 2030 (USD Billion)
- 8.4.2. Canada
  - 8.4.2.1. Key country dynamics
  - 8.4.2.2. Competitive scenario
  - 8.4.2.3. Regulatory framework
  - 8.4.2.4. Canada market estimates and forecasts 2018 - 2030 (USD Billion)
- 8.4.3. Mexico
  - 8.4.3.1. Key country dynamics
  - 8.4.3.2. Competitive scenario
  - 8.4.3.3. Regulatory framework
  - 8.4.3.4. Mexico market estimates and forecasts 2018 - 2030 (USD Billion)
8.5. Europe
- 8.5.1. UK
  - 8.5.1.1. Key country dynamics
  - 8.5.1.2. Competitive scenario
  - 8.5.1.3. Regulatory framework
  - 8.5.1.4. UK market estimates and forecasts 2018 - 2030 (USD Billion)
- 8.5.2. Germany
  - 8.5.2.1. Key country dynamics
  - 8.5.2.2. Competitive scenario
  - 8.5.2.3. Regulatory framework
  - 8.5.2.4. Germany market estimates and forecasts 2018 - 2030 (USD Billion)
- 8.5.3. France
  - 8.5.3.1. Key country dynamics
  - 8.5.3.2. Competitive scenario
  - 8.5.3.3. Regulatory framework
  - 8.5.3.4. France market estimates and forecasts 2018 - 2030 (USD Billion)
- 8.5.4. Italy
  - 8.5.4.1. Key country dynamics
  - 8.5.4.2. Competitive scenario
  - 8.5.4.3. Regulatory framework
  - 8.5.4.4. Italy market estimates and forecasts 2018 - 2030 (USD Billion)
- 8.5.5. Spain
  - 8.5.5.1. Key country dynamics
  - 8.5.5.2. Competitive scenario
  - 8.5.5.3. Regulatory framework
  - 8.5.5.4. Spain market estimates and forecasts 2018 - 2030 (USD Billion)
- 8.5.6. Denmark
  - 8.5.6.1. Key country dynamics
  - 8.5.6.2. Competitive scenario
  - 8.5.6.3. Denmark market estimates and forecasts 2018 - 2030 (USD Billion)
- 8.5.7. Sweden
  - 8.5.7.1. Key country dynamics
  - 8.5.7.2. Competitive scenario
  - 8.5.7.3. Regulatory framework
  - 8.5.7.4. Sweden market estimates and forecasts 2018 - 2030 (USD Billion)
- 8.5.8. Norway
  - 8.5.8.1. Key country dynamics
  - 8.5.8.2. Competitive scenario
  - 8.5.8.3. Regulatory framework
  - 8.5.8.4. Norway market estimates and forecasts 2018 - 2030 (USD Billion)
8.6. Asia Pacific
- 8.6.1. Japan
  - 8.6.1.1. Key country dynamics
  - 8.6.1.2. Competitive scenario
  - 8.6.1.3. Regulatory framework
  - 8.6.1.4. Japan market estimates and forecasts 2018 - 2030 (USD Billion)
- 8.6.2. China
  - 8.6.2.1. Key country dynamics
  - 8.6.2.2. Competitive scenario
  - 8.6.2.3. Regulatory framework
  - 8.6.2.4. China market estimates and forecasts 2018 - 2030 (USD Billion)
- 8.6.3. India
  - 8.6.3.1. Key country dynamics
  - 8.6.3.2. Competitive scenario
  - 8.6.3.3. Regulatory framework
  - 8.6.3.4. India market estimates and forecasts 2018 - 2030 (USD Billion)
- 8.6.4. Australia
  - 8.6.4.1. Key country dynamics
  - 8.6.4.2. Competitive scenario
  - 8.6.4.3. Regulatory framework
  - 8.6.4.4. Australia market estimates and forecasts 2018 - 2030 (USD Billion)
- 8.6.5. South Korea
  - 8.6.5.1. Key country dynamics
  - 8.6.5.2. Competitive scenario
  - 8.6.5.3. Regulatory framework
  - 8.6.5.4. South Korea market estimates and forecasts 2018 - 2030 (USD Billion)
- 8.6.6. Thailand
  - 8.6.6.1. Key country dynamics
  - 8.6.6.2. Competitive scenario
  - 8.6.6.3. Regulatory framework
  - 8.6.6.4. Thailand market estimates and forecasts 2018 - 2030 (USD Billion)
8.7. Latin America
- 8.7.1. Brazil
  - 8.7.1.1. Key country dynamics
  - 8.7.1.2. Competitive scenario
  - 8.7.1.3. Regulatory framework
  - 8.7.1.4. Brazil market estimates and forecasts 2018 - 2030 (USD Billion)
- 8.7.2. Argentina
  - 8.7.2.1. Key country dynamics
  - 8.7.2.2. Competitive scenario
  - 8.7.2.3. Regulatory framework
  - 8.7.2.4. Argentina market estimates and forecasts 2018 - 2030 (USD Billion)
8.8. MEA
- 8.8.1. South Africa
  - 8.8.1.1. Key country dynamics
  - 8.8.1.2. Competitive scenario
  - 8.8.1.3. Regulatory framework
  - 8.8.1.4. South Africa market estimates and forecasts 2018 - 2030 (USD Billion)
- 8.8.2. Saudi Arabia
  - 8.8.2.1. Key country dynamics
  - 8.8.2.2. Competitive scenario
  - 8.8.2.3. Saudi Arabia market estimates and forecasts 2018 - 2030 (USD Billion)
- 8.8.3. UAE
  - 8.8.3.1. Key country dynamics
  - 8.8.3.2. Competitive scenario
  - 8.8.3.3. Regulatory framework
  - 8.8.3.4. UAE market estimates and forecasts 2018 - 2030 (USD Billion)
- 8.8.4. Kuwait
  - 8.8.4.1. Key country dynamics
  - 8.8.4.2. Competitive scenario
  - 8.8.4.3. Regulatory framework
  - 8.8.4.4. Kuwait market estimates and forecasts 2018 - 2030 (USD Billion)

Chapter 9. Competitive Landscape

9.1. Company/Competition Categorization
9.2. Strategy Mapping
9.3. Company Market Position Analysis, 2023
9.4. List of Key Certification Providers/Scheme Owners
9.5. Company Profiles/Listing
- 9.5.1. Ocular Therapeutix Inc.
  - 9.5.1.1. Company overview
  - 9.5.1.2. Financial performance
  - 9.5.1.3. Technology benchmarking
  - 9.5.1.4. Strategic initiatives
- 9.5.2. Allergan plc.
  - 9.5.2.1. Company overview
  - 9.5.2.2. Financial performance
  - 9.5.2.3. Technology benchmarking
  - 9.5.2.4. Strategic initiatives
- 9.5.3. Santen Pharmaceutical Co. Ltd.
  - 9.5.3.1. Company overview
  - 9.5.3.2. Financial performance
  - 9.5.3.3. Technology benchmarking
  - 9.5.3.4. Strategic initiatives
- 9.5.4. Envisia Therapeutics
  - 9.5.4.1. Company overview
  - 9.5.4.2. Financial performance
  - 9.5.4.3. Technology benchmarking
  - 9.5.4.4. Strategic initiatives
- 9.5.5. pSivida
  - 9.5.5.1. Company overview
  - 9.5.5.2. Financial performance
  - 9.5.5.3. Technology benchmarking
  - 9.5.5.4. Strategic initiatives
- 9.5.6. Clearside Biomedical
  - 9.5.6.1. Company overview
  - 9.5.6.2. Financial performance
  - 9.5.6.3. Technology benchmarking
  - 9.5.6.4. Strategic initiatives
- 9.5.7. Oculis Pharma
  - 9.5.7.1. Company overview
  - 9.5.7.2. Financial performance
  - 9.5.7.3. Technology benchmarking
  - 9.5.7.4. Strategic initiatives
- 9.5.8. Valeant Pharmaceuticals
  - 9.5.8.1. Company overview
  - 9.5.8.2. Financial performance
  - 9.5.8.3. Technology benchmarking
  - 9.5.8.4. Strategic initiatives
- 9.5.9. AptarGroup, Inc.
- 9.5.9. Company overview
  - 9.5.9.1. Financial performance
  - 9.5.9.2. Technology benchmarking
  - 9.5.9.3. Strategic initiatives

Product Code: GVR-4-68039-917-7

List of Tables

Table 1 List of abbreviation
Table 2 Global ophthalmic drug delivery systems market, by region, 2018 - 2030 (USD Billion)
Table 3 Global ophthalmic drug delivery systems market, by technology, 2018 - 2030 (USD Billion)
Table 4 Global ophthalmic drug delivery systems market, by delivery route, 2018 - 2030 (USD Billion)
Table 5 Global ophthalmic drug delivery systems market, by production technology, 2018 - 2030 (USD Billion)
Table 6 Global ophthalmic drug delivery systems market, by material, 2018 - 2030 (USD Billion)
Table 7 North America ophthalmic drug delivery systems market, by country, 2018 - 2030 (USD Billion)
Table 8 North America ophthalmic drug delivery systems market, by technology, 2018 - 2030 (USD Billion)
Table 9 North America ophthalmic drug delivery systems market, by delivery route, 2018 - 2030 (USD Billion)
Table 10 North America ophthalmic drug delivery systems market, by production technology, 2018 - 2030 (USD Billion)
Table 11 North America ophthalmic drug delivery systems market, by material, 2018 - 2030 (USD Billion)
Table 12 U.S. ophthalmic drug delivery systems market, by technology, 2018 - 2030 (USD Billion)
Table 13 U.S. ophthalmic drug delivery systems market, by delivery route, 2018 - 2030 (USD Billion)
Table 14 U.S. ophthalmic drug delivery systems market, by production technology, 2018 - 2030 (USD Billion)
Table 15 U.S. ophthalmic drug delivery systems market, by material, 2018 - 2030 (USD Billion)
Table 16 Canada ophthalmic drug delivery systems market, by technology, 2018 - 2030 (USD Billion)
Table 17 Canada ophthalmic drug delivery systems market, by delivery route, 2018 - 2030 (USD Billion)
Table 18 Canada ophthalmic drug delivery systems market, by production technology, 2018 - 2030 (USD Billion)
Table 19 Canada ophthalmic drug delivery systems market, by material, 2018 - 2030 (USD Billion)
Table 20 Mexico ophthalmic drug delivery systems market, by technology, 2018 - 2030 (USD Billion)
Table 21 Mexico ophthalmic drug delivery systems market, by delivery route, 2018 - 2030 (USD Billion)
Table 22 Mexico ophthalmic drug delivery systems market, by production technology, 2018 - 2030 (USD Billion)
Table 23 Mexico ophthalmic drug delivery systems market, by material, 2018 - 2030 (USD Billion)
Table 24 Europe ophthalmic drug delivery systems market, by country, 2018 - 2030 (USD Billion)
Table 25 Europe ophthalmic drug delivery systems market, by technology, 2018 - 2030 (USD Billion)
Table 26 Europe ophthalmic drug delivery systems market, by delivery route, 2018 - 2030 (USD Billion)
Table 27 Europe ophthalmic drug delivery systems market, by production technology, 2018 - 2030 (USD Billion)
Table 28 Europe ophthalmic drug delivery systems market, by material, 2018 - 2030 (USD Billion)
Table 29 UK ophthalmic drug delivery systems market, by technology, 2018 - 2030 (USD Billion)
Table 30 UK ophthalmic drug delivery systems market, by delivery route, 2018 - 2030 (USD Billion)
Table 31 UK ophthalmic drug delivery systems market, by production technology, 2018 - 2030 (USD Billion)
Table 32 UK ophthalmic drug delivery systems market, by material, 2018 - 2030 (USD Billion)
Table 33 Germany ophthalmic drug delivery systems market, by technology, 2018 - 2030 (USD Billion)
Table 34 Germany ophthalmic drug delivery systems market, by delivery route, 2018 - 2030 (USD Billion)
Table 35 Germany ophthalmic drug delivery systems market, by production technology, 2018 - 2030 (USD Billion)
Table 36 Germany ophthalmic drug delivery systems market, by material, 2018 - 2030 (USD Billion)
Table 37 France ophthalmic drug delivery systems market, by technology, 2018 - 2030 (USD Billion)
Table 38 France ophthalmic drug delivery systems market, by delivery route, 2018 - 2030 (USD Billion)
Table 39 France ophthalmic drug delivery systems market, by production technology, 2018 - 2030 (USD Billion)
Table 40 France ophthalmic drug delivery systems market, by material, 2018 - 2030 (USD Billion)
Table 41 Italy ophthalmic drug delivery systems market, by technology, 2018 - 2030 (USD Billion)
Table 42 Italy ophthalmic drug delivery systems market, by delivery route, 2018 - 2030 (USD Billion)
Table 43 Italy ophthalmic drug delivery systems market, by production technology, 2018 - 2030 (USD Billion)
Table 44 Italy ophthalmic drug delivery systems market, by material, 2018 - 2030 (USD Billion)
Table 45 Spain ophthalmic drug delivery systems market, by technology, 2018 - 2030 (USD Billion)
Table 46 Spain ophthalmic drug delivery systems market, by delivery route, 2018 - 2030 (USD Billion)
Table 47 Spain ophthalmic drug delivery systems market, by production technology, 2018 - 2030 (USD Billion)
Table 48 Spain ophthalmic drug delivery systems market, by material, 2018 - 2030 (USD Billion)
Table 49 Denmark ophthalmic drug delivery systems market, by technology, 2018 - 2030 (USD Billion)
Table 50 Denmark ophthalmic drug delivery systems market, by delivery route, 2018 - 2030 (USD Billion)
Table 51 Denmark ophthalmic drug delivery systems market, by production technology, 2018 - 2030 (USD Billion)
Table 52 Denmark ophthalmic drug delivery systems market, by material, 2018 - 2030 (USD Billion)
Table 53 Sweden ophthalmic drug delivery systems market, by technology, 2018 - 2030 (USD Billion)
Table 54 Sweden ophthalmic drug delivery systems market, by delivery route, 2018 - 2030 (USD Billion)
Table 55 Sweden ophthalmic drug delivery systems market, by production technology, 2018 - 2030 (USD Billion)
Table 56 Sweden ophthalmic drug delivery systems market, by material, 2018 - 2030 (USD Billion)
Table 57 Norway ophthalmic drug delivery systems market, by technology, 2018 - 2030 (USD Billion)
Table 58 Norway ophthalmic drug delivery systems market, by delivery route, 2018 - 2030 (USD Billion)
Table 59 Norway ophthalmic drug delivery systems market, by production technology, 2018 - 2030 (USD Billion)
Table 60 Norway ophthalmic drug delivery systems market, by material, 2018 - 2030 (USD Billion)
Table 61 Asia Pacific ophthalmic drug delivery systems market, by country, 2018 - 2030 (USD Billion)
Table 62 Asia Pacific ophthalmic drug delivery systems market, by technology, 2018 - 2030 (USD Billion)
Table 63 Asia Pacific ophthalmic drug delivery systems market, by delivery route, 2018 - 2030 (USD Billion)
Table 64 Asia Pacific ophthalmic drug delivery systems market, by production technology, 2018 - 2030 (USD Billion)
Table 65 Asia Pacific ophthalmic drug delivery systems market, by material, 2018 - 2030 (USD Billion)
Table 66 Japan ophthalmic drug delivery systems market, by technology, 2018 - 2030 (USD Billion)
Table 67 Japan ophthalmic drug delivery systems market, by delivery route, 2018 - 2030 (USD Billion)
Table 68 Japan ophthalmic drug delivery systems market, by production technology, 2018 - 2030 (USD Billion)
Table 69 Japan ophthalmic drug delivery systems market, by material, 2018 - 2030 (USD Billion)
Table 70 China ophthalmic drug delivery systems market, by technology, 2018 - 2030 (USD Billion)
Table 71 China ophthalmic drug delivery systems market, by production technology, 2018 - 2030 (USD Billion)
Table 72 China ophthalmic drug delivery systems market, by delivery route, 2018 - 2030 (USD Billion)
Table 73 China ophthalmic drug delivery systems market, by material, 2018 - 2030 (USD Billion)
Table 74 India ophthalmic drug delivery systems market, by technology, 2018 - 2030 (USD Billion)
Table 75 India ophthalmic drug delivery systems market, by delivery route, 2018 - 2030 (USD Billion)
Table 76 India ophthalmic drug delivery systems market, by production technology, 2018 - 2030 (USD Billion)
Table 77 India ophthalmic drug delivery systems market, by material, 2018 - 2030 (USD Billion)
Table 78 Australia ophthalmic drug delivery systems market, by technology, 2018 - 2030 (USD Billion)
Table 79 Australia ophthalmic drug delivery systems market, by delivery route, 2018 - 2030 (USD Billion)
Table 80 Australia ophthalmic drug delivery systems market, by production technology, 2018 - 2030 (USD Billion)
Table 81 Australia ophthalmic drug delivery systems market, by material, 2018 - 2030 (USD Billion)
Table 82 South Korea ophthalmic drug delivery systems market, by technology, 2018 - 2030 (USD Billion)
Table 83 South Korea ophthalmic drug delivery systems market, by delivery route, 2018 - 2030 (USD Billion)
Table 84 South Korea ophthalmic drug delivery systems market, by production technology, 2018 - 2030 (USD Billion)
Table 85 South Korea ophthalmic drug delivery systems market, by material, 2018 - 2030 (USD Billion)
Table 86 Thailand ophthalmic drug delivery systems market, by technology, 2018 - 2030 (USD Billion)
Table 87 Thailand ophthalmic drug delivery systems market, by delivery route, 2018 - 2030 (USD Billion)
Table 88 Thailand ophthalmic drug delivery systems market, by production technology, 2018 - 2030 (USD Billion)
Table 89 Thailand ophthalmic drug delivery systems market, by material, 2018 - 2030 (USD Billion)
Table 90 Latin America ophthalmic drug delivery systems market, by country, 2018 - 2030 (USD Billion)
Table 91 Latin America ophthalmic drug delivery systems market, by technology, 2018 - 2030 (USD Billion)
Table 92 Latin America ophthalmic drug delivery systems market, by delivery route, 2018 - 2030 (USD Billion)
Table 93 Latin America ophthalmic drug delivery systems market, by production technology, 2018 - 2030 (USD Billion)
Table 94 Latin America ophthalmic drug delivery systems market, by material, 2018 - 2030 (USD Billion)
Table 95 Brazil ophthalmic drug delivery systems market, by technology, 2018 - 2030 (USD Billion)
Table 96 Brazil ophthalmic drug delivery systems market, by delivery route, 2018 - 2030 (USD Billion)
Table 97 Brazil ophthalmic drug delivery systems market, by production technology, 2018 - 2030 (USD Billion)
Table 98 Brazil ophthalmic drug delivery systems market, by material, 2018 - 2030 (USD Billion)
Table 99 Argentina ophthalmic drug delivery systems market, by technology, 2018 - 2030 (USD Billion)
Table 100 Argentina ophthalmic drug delivery systems market, by delivery route, 2018 - 2030 (USD Billion)
Table 101 Argentina ophthalmic drug delivery systems market, by production technology, 2018 - 2030 (USD Billion)
Table 102 Argentina ophthalmic drug delivery systems market, by material, 2018 - 2030 (USD Billion)
Table 103 MEA ophthalmic drug delivery systems market, by country, 2018 - 2030 (USD Billion)
Table 104 MEA ophthalmic drug delivery systems market, by technology, 2018 - 2030 (USD Billion)
Table 105 MEA ophthalmic drug delivery systems market, by delivery route, 2018 - 2030 (USD Billion)
Table 106 MEA ophthalmic drug delivery systems market, by production technology, 2018 - 2030 (USD Billion)
Table 107 MEA ophthalmic drug delivery systems market, by material, 2018 - 2030 (USD Billion)
Table 108 South Africa ophthalmic drug delivery systems market, by technology, 2018 - 2030 (USD Billion)
Table 109 South Africa ophthalmic drug delivery systems market, by delivery route, 2018 - 2030 (USD Billion)
Table 110 South Africa ophthalmic drug delivery systems market, by production technology, 2018 - 2030 (USD Billion)
Table 111 South Africa ophthalmic drug delivery systems market, by material, 2018 - 2030 (USD Billion)
Table 112 Saudi Arabia ophthalmic drug delivery systems market, by technology, 2018 - 2030 (USD Billion)
Table 113 Saudi Arabia ophthalmic drug delivery systems market, by delivery route, 2018 - 2030 (USD Billion)
Table 114 Saudi Arabia ophthalmic drug delivery systems market, by production technology, 2018 - 2030 (USD Billion)
Table 115 Saudi Arabia ophthalmic drug delivery systems market, by material, 2018 - 2030 (USD Billion)
Table 116 UAE ophthalmic drug delivery systems market, by technology, 2018 - 2030 (USD Billion)
Table 117 UAE ophthalmic drug delivery systems market, by delivery route, 2018 - 2030 (USD Billion)
Table 118 UAE ophthalmic drug delivery systems market, by production technology, 2018 - 2030 (USD Billion)
Table 119 UAE ophthalmic drug delivery systems market, by material, 2018 - 2030 (USD Billion)
Table 120 Kuwait ophthalmic drug delivery systems market, by technology, 2018 - 2030 (USD Billion)
Table 121 Kuwait ophthalmic drug delivery systems market, by delivery route, 2018 - 2030 (USD Billion)
Table 122 Kuwait ophthalmic drug delivery systems market, by production technology, 2018 - 2030 (USD Billion)
Table 123 Kuwait ophthalmic drug delivery systems market, by material, 2018 - 2030 (USD Billion)

List of Figures

Fig. 1 Ophthalmic drug delivery systems market segmentation
Fig. 2 Data analysis models
Fig. 3 Market formulation and validation
Fig. 4 Data validating & publishing
Fig. 5 Market research process
Fig. 6 Information procurement
Fig. 7 Primary research
Fig. 8 Value-chain-based sizing & forecasting
Fig. 9 QFD modelling for market share assessment
Fig. 10 Market formulation & validation
Fig. 11 Commodity flow analysis
Fig. 12 Market outlook
Fig. 13 Segment snapshot-1
Fig. 14 Segment snapshot-2
Fig. 15 Competitive landscape snapshot
Fig. 16 Market trends & outlook
Fig. 17 Porter's five force analysis
Fig. 18 PESTEL analysis
Fig. 19 Ophthalmic drug delivery systems market: Technology outlook key takeaways
Fig. 20 Ophthalmic drug delivery systems market: Technology movement analysis
Fig. 21 Eye drops market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 22 Contact lenses market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 23 Punctal plugs market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 24 Episcleral implants market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 25 Intravitreal implants market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 26 Injectable particulate systems market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 27 Iontophoresis market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 28 Micro-Electromechanical market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 29 Nano careers market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 30 Nano microparticles market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 31 Microneedles market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 32 Hydrogels market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 33 Others market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 34 Ophthalmic drug delivery systems market: Delivery route outlook key takeaways
Fig. 35 Ophthalmic drug delivery systems market: Delivery route movement analysis
Fig. 36 Intraocular market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 37 Intravitreal market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 38 Intracameral market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 39 Ophthalmic drug delivery systems market: Production technology outlook key takeaways
Fig. 40 Ophthalmic drug delivery systems market: Production technology movement analysis
Fig. 41 Electrospinning market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 42 3D printing market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 43 Formulation market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 44 Micro patterning market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 45 Compression molding market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 46 Others market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 47 Ophthalmic drug delivery systems market: Material outlook key takeaways
Fig. 48 Ophthalmic drug delivery systems market: Material movement analysis
Fig. 49 Liposomes market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 50 Collagen market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 51 PLA-PEG market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 52 PDO/PVA market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 53 Hydrogels market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 54 TMC market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 55 Polyorthoesters market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 56 PLGA market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 57 Polycaprolactone market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 58 Fatty acids market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 59 Others market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 60 Regional marketplace outlook, 2024 & 2030 (USD Billion)
Fig. 61 Regional marketplace: Key takeaways
Fig. 62 North America ophthalmic drug delivery systems market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 63 Key country dynamics
Fig. 64 U.S. ophthalmic drug delivery systems market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 65 Key country dynamics
Fig. 66 Canada ophthalmic drug delivery systems market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 67 Key country dynamics
Fig. 68 Mexico ophthalmic drug delivery systems market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 69 Europe ophthalmic drug delivery systems market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 70 Key country dynamics
Fig. 71 UK ophthalmic drug delivery systems market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 72 Key country dynamics
Fig. 73 Germany ophthalmic drug delivery systems market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 74 Key country dynamics
Fig. 75 France ophthalmic drug delivery systems market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 76 Key country dynamics
Fig. 77 Spain ophthalmic drug delivery systems market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 78 Key country dynamics
Fig. 79 Italy ophthalmic drug delivery systems market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 80 Key country dynamics
Fig. 81 Denmark ophthalmic drug delivery systems market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 82 Key country dynamics
Fig. 83 Sweden ophthalmic drug delivery systems market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 84 Key country dynamics
Fig. 85 Norway ophthalmic drug delivery systems market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 86 Asia Pacific ophthalmic drug delivery systems market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 87 Key country dynamics
Fig. 88 Japan ophthalmic drug delivery systems market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 89 Key country dynamics
Fig. 90 China ophthalmic drug delivery systems market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 91 Key country dynamics
Fig. 92 India ophthalmic drug delivery systems market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 93 Key country dynamics
Fig. 94 Australia ophthalmic drug delivery systems market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 95 Key country dynamics
Fig. 96 South Korea ophthalmic drug delivery systems market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 97 Key country dynamics
Fig. 98 Thailand ophthalmic drug delivery systems market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 99 Key country dynamics
Fig. 100 Market participant categorization
Fig. 101 Ophthalmic drug delivery systems market position analysis, 2023
Fig. 102 Strategic framework